IDC Perspective: How Technology Is Driving Diversity and Equity in Clinical Trials

This IDC Perspective reviews the existing landscape and critical challenges associated with driving diversity and equity in clinical trials. It reviews strategies that pharma is using to address these challenges and scans the evolving technology landscape that is playing a critical role in driving change. It also examines regulatory policies and guidances, identifies the key measures of success, and provides guidance on implementing a diversity strategy."Inclusive clinical development is a must to address the deep-rooted disparities that prevail across the globe. There is no silver bullet to address this issue. It requires a focused, sustained, and collaborative effort; it requires sensitivity and empathy to be woven into technology and strategy; and it calls for a genuine deep-seated commitment toward driving inclusiveness and equity in clinical trials," says Dr. Nimita Limaye, research vice president, Life Sciences R&D Strategy and Technology at IDC Health Insights.